{"slideshow_credits": null, "snippet": "The new Obama administration rules will ultimately discourage companies from investing in the U.S.", "abstract": "Op-Ed article by economist Diana Furchgott-Roth argues new Treasury Dept regulations aimed at limiting corporate inversions are unlikely to benefit United Sates; holds country's high statutory corporate taxes unfairly punish American-based multinationals; suggests solution is lower taxes, not burdensome new rules.", "section_name": "Opinion", "print_page": "25", "document_type": "article", "byline": {"person": [{"firstname": "Diana", "role": "reported", "lastname": "FURCHTGOTT-ROTH", "rank": 1, "organization": ""}], "original": "By DIANA FURCHTGOTT-ROTH"}, "web_url": "http://www.nytimes.com/2016/04/08/opinion/free-pfizer-why-inversions-are-good-for-the-us.html", "lead_paragraph": "The new Obama administration rules will ultimately discourage companies from investing in the U.S.", "headline": {"print_headline": "Free Pfizer! Why Inversions Help", "main": "Free Pfizer! Why Inversions Are Good for the U.S.", "content_kicker": "Op-Ed Contributor", "kicker": "Op-Ed Contributor"}, "_id": "5706ce4138f0d80c57594f1e", "word_count": "842", "multimedia": [{"height": 126, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 454, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/07/opinion/08furchtgott/08furchtgott-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "454"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/07/opinion/08furchtgott/08furchtgott-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-04-08T00:00:00Z", "source": "The New York Times", "news_desk": "OpEd", "keywords": [{"name": "subject", "value": "Corporate Taxes", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Treasury Department", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Tax Shelters", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}, {"name": "organizations", "value": "ALLERGAN INC", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Pfizer Inc", "is_major": "N", "rank": "6"}, {"name": "subject", "value": "Federal Taxes (US)", "is_major": "N", "rank": "7"}, {"name": "persons", "value": "Obama, Barack", "is_major": "N", "rank": "8"}, {"name": "organizations", "value": "Internal Revenue Service", "is_major": "N", "rank": "9"}], "blog": [], "subsection_name": null, "type_of_material": "Op-Ed"}